RONKONKOMA, N.Y., July 27 /PRNewswire-FirstCall/ -- NBTY, Inc.
(NYSE:NTY) (http://www.nbty.com/), a leading global manufacturer
and marketer of nutritional supplements, today announced results
for the fiscal third quarter and nine months ended June 30, 2009.
For the fiscal third quarter ended June 30, 2009, net sales were
$652 million compared to $535 million for the fiscal third quarter
ended June 30, 2008, an increase of $117 million or 22%. Included
in this total are net sales of $27 million from Julian Graves,
which NBTY acquired in September 2008. The Leiner Health Products
business, which was acquired in July 2008, has been fully
integrated into NBTY operations and accordingly, its sales can no
longer be separately identified. Net income for the fiscal third
quarter ended June 30, 2009 was $46 million, or $0.73 per diluted
share, which is comparable to the $46 million, or $0.72 per diluted
share, for the fiscal third quarter ended June 30, 2008. Net income
for the fiscal third quarter reflects operational efficiencies and
improved supply chain management. Included in expenses for the
quarter were the following: $10 million for terminated IT projects
determined to be ineffective and uneconomical, $4 million in legal
expenses associated with Julian Graves Competition Commission
issues in the UK, and a $3 million impairment charge to record the
current market value of an idle plant. The aggregate after-tax
impact of these items was $0.17 per diluted share. Adjusted EBITDA
for the fiscal third quarter of 2009 was a record $109 million,
compared to $87 million for the fiscal third quarter of 2008. The
Company's balance sheet continues to be strong and well
capitalized. At June 30, 2009, working capital was $614 million,
total assets were $1.9 billion, $325 million remains undrawn under
the Company's Revolving Credit Facility, and book value per share
was $17.24. OPERATIONS FOR THE FISCAL THIRD QUARTER ENDED JUNE 30,
2009 Overall gross profit margins for the fiscal third quarter of
2009 were 45% compared to 51% for the fiscal third quarter of 2008.
This reflects an on-going trend of private label sales constituting
a greater portion of the Company's overall sales. Private label
sales traditionally have a lower gross profit and, accordingly,
overall gross profit margin decreased. Net sales for the
Wholesale/US Nutrition division, which markets various brands
including Nature's Bounty, Osteo Bi-Flex, Rexall, Sundown, Ester-C,
Solgar, and private label products, increased $113 million, or 40%,
to $396 million. The Nielsen Company tracks industry-wide sales of
vitamins, minerals, herbs and other supplements in the food, drug
and mass market sectors. For the thirteen week period ended June
27, 2009, Nielsen reported an increase in the entire category of
9.8%. According to Nielsen, for that same period, the Company's
Wholesale brands reported a 10.5% increase. The Wholesale/US
Nutrition division utilizes valuable consumer preference sales data
generated by the Company's Vitamin World retail stores and
Puritan's Pride Direct Response/E-Commerce operations to empower
its wholesale customers with this latest data. The Vitamin World
stores are used as a laboratory for new ideas and are an effective
tool in determining and monitoring consumer preferences. This
information, as well as scanned sales data from the Vitamin World
stores, is shared on a real time basis with our wholesale customers
to give them a competitive advantage. Net sales for the North
American Retail division, comprised of Vitamin World Stores in the
United States and LeNaturiste stores in Canada, were $51 million,
compared to $50 million, for the prior like quarter. While
operating in a difficult retail environment in the US and Canada,
the Division's same store sales increased 1% for the fiscal third
quarter of 2009. Vitamin World's modernization of its stores had a
favorable impact on its operations in the fiscal third quarter.
During the fiscal third quarter of 2009, the North American Retail
division closed 4 stores and added 1 new store. At the end of the
fiscal third quarter of 2009, the North American Retail division
operated a total of 528 stores, consisting of 442 Vitamin World
stores in the United States and 86 LeNaturiste stores in Canada.
European Retail net sales for the fiscal third quarter ended June
30, 2009 were $151 million compared to $146 million, for the prior
like quarter. European Retail net sales for the third fiscal
quarter include $27 million from Julian Graves, which NBTY acquired
in September 2008. Excluding Julian Graves sales, European Retail
net sales increased 8% in local currency (British Pound Sterling),
and decreased 14% in US dollars for the third fiscal quarter,
compared to the prior like quarter. European Retail division same
store sales in local currency increased 6% from the prior like
period. The Julian Graves acquisition was provisionally approved by
the UK Competition Commission on July 22, 2009. The final decision
by the UK Competition Commission is expected on or before September
3, 2009. During the third fiscal quarter Julian Graves operated at
a breakeven despite not being integrated with the Company's
European operations. The European Retail division continues to
leverage its premier status, high street locations and brand
awareness in a difficult retail environment. The European Retail
division consists of 534 Holland & Barrett stores, 350 Julian
Graves stores and 31 GNC stores in the UK, 24 Nature's Way stores
in Ireland, and 73 DeTuinen stores in the Netherlands, for a total
of 1,012 stores in Europe. During the fiscal third quarter of 2009,
Holland & Barrett opened 2 franchised stores in South Africa,
for a total of 9 franchised stores in South Africa. Net sales from
Direct Response/E-Commerce operations for the fiscal third quarter
of 2009 decreased $2 million, or 3% to $53 million from $55 million
for the fiscal third quarter of 2008. As this division varies its
promotional strategy throughout the fiscal year, its results should
be viewed on an annual and not quarterly basis. For the fiscal
third quarter of 2009, compared with the prior like quarter, gross
profit percentage for this division increased 6% to 64%; average
order size increased $11.57 to $77.37. Puritan's Pride is the
leader in the Direct Response and E-Commerce sectors and continues
to increase the number of products available via its catalog and
web sites. OPERATIONS FOR THE FISCAL NINE MONTHS ENDED JUNE 30,
2009 For the fiscal nine months ended June 30, 2009, net sales were
$1.9 billion compared to $1.6 billion for the fiscal nine months
ended June 30, 2008, an increase of $330 million or 21%. Net income
for the fiscal nine months ended June 30, 2009 was $82 million, or
$1.31 per diluted share, compared to $136 million, or $2.06 per
diluted share, for the fiscal nine months ended June 30, 2008. Net
income for the fiscal nine months ended June 30, 2009 reflects the
improved operations for the third quarter, decreases in foreign
exchange rates, terminated IT project costs and the aforementioned
other costs. The aggregate after-tax impact of these items was
$0.27 per diluted share. Overall gross profit margins for the
fiscal nine months ended June 30, 2009 were 43% compared to 52% for
the fiscal nine months ended June 30, 2008. As a result of the
Leiner acquisition, during the first and second fiscal quarters,
the Company experienced lower gross margins on the private label
business and additional cost pressures as Leiner inventory levels
were not adequate to maintain customer fulfillment levels at the
time of its acquisition. In order to maintain adequate customer
fulfillment levels, NBTY purchased products at higher costs which
negatively impacted results. NBTY Chairman and CEO, Scott Rudolph,
said: "NBTY generated a significant increase in sales for the
quarter, particularly in our wholesale sector, which continues to
benefit from the Leiner acquisition. We are now experiencing
operating leverage generating long-term growth, garnering greater
market share and enhancing our position as the global leader in the
nutritional supplement industry." ABOUT NBTY NBTY is a leading
global vertically integrated manufacturer, marketer and distributor
of a broad line of high-quality, value-priced nutritional
supplements in the United States and throughout the world. Under a
number of NBTY and third party brands, the Company offers over
25,000 products, including products marketed by the Company's
Nature's Bounty (http://www.naturesbounty.com/), Vitamin World
(http://www.vitaminworld.com/), Puritan's Pride
(http://www.puritan.com/), Holland & Barrett
(http://www.hollandandbarrett.com/), Rexall
(http://www.rexall.com/), Sundown
(http://www.sundownnutrition.com/), MET-Rx (http://www.metrx.com/),
Worldwide Sport Nutrition (http://www.sportnutrition.com/),
American Health (http://www.americanhealthus.com/), GNC (UK)
(http://www.gnc.co.uk/), DeTuinen (http://www.detuinen.nl/),
LeNaturiste(TM) (http://www.lenaturiste.com/), SISU
(http://www.sisu.com/), Solgar (http://www.solgar.com/), Good 'n'
Natural (http://www.goodnnatural.com/), Home Health(TM)
(http://www.homehealthus.com/), Julian Graves, and Ester-C
(http://www.ester-c.com/) brands. NBTY routinely posts information
that may be important to investors on its web site. This release
refers to non-GAAP financial measures, such as Adjusted EBITDA.
"Adjusted EBITDA" is defined as net income, excluding the aggregate
amount of all non-cash losses reducing net income, plus interest,
taxes, depreciation and amortization. This non-GAAP financial
measure is not prepared in accordance with generally accepted
accounting principles and may be different from non-GAAP financial
measures used by other companies. Non-GAAP financial measures
should not be considered as a substitute for, or superior to,
measures of financial performance prepared in accordance with GAAP.
A reconciliation of the non-GAAP measure to the comparable GAAP
measure is included in the attached financial tables. Management
believes the presentation of Adjusted EBITDA is relevant and useful
because Adjusted EBITDA is a measurement industry analysts utilize
when evaluating NBTY's operating performance. Management also
believes Adjusted EBITDA enhances an investor's understanding of
NBTY's results of operations because it measures NBTY's operating
performance exclusive of interest and non-cash charges for
depreciation and amortization. Management also provides this
non-GAAP measurement as a way to help investors better understand
its core operating performance, enhance comparisons of NBTY's core
operating performance from period to period and to allow better
comparisons of NBTY's operating performance to that of its
competitors. This release contains certain forward-looking
statements within the meaning of the Private Securities Litigation
Reform Act of 1995 with respect to our financial condition, results
of operations and business. These forward-looking statements can be
identified by the use of terminology such as "subject to,"
"believe," "expects," "plan," "project," "estimate," "intend,"
"may," "will," "should," "can," or "anticipates," or the negative
thereof, or variations thereon, or comparable terminology, or by
discussions of strategy. Although all of these forward looking
statements are believed to be reasonable, they are inherently
uncertain. Factors which may materially affect such forward-looking
statements include: (i) slow or negative growth in the nutritional
supplement industry; (ii) interruption of business or negative
impact on sales and earnings due to acts of God, acts of war,
terrorism, bio- terrorism, civil unrest or disruption of mail
service; (iii) adverse publicity regarding nutritional supplements;
(iv) inability to retain customers of companies (or mailing lists)
recently acquired; (v) increased competition; (vi) increased costs;
(vii) loss or retirement of key members of management; (viii)
increases in the cost of borrowings and/or unavailability of
additional debt or equity capital; (ix) unavailability of, or
inability to consummate, advantageous acquisitions in the future,
including those that may be subject to bankruptcy approval or the
inability of NBTY to integrate acquisitions into the mainstream of
its business; (x) changes in general worldwide economic and
political conditions in the markets in which NBTY may compete from
time to time; (xi) the inability of NBTY to gain and/or hold market
share of its wholesale and/or retail customers anywhere in the
world; (xii) unavailability of electricity in certain geographical
areas; (xiii) the inability of NBTY to obtain and/or renew
insurance and/or the costs of the same; (xiv) exposure to and
expense of defending and resolving product liability and
intellectual property claims and other litigation; (xv) the ability
of NBTY to successfully implement its business strategy; (xvi) the
inability of NBTY to manage its retail, wholesale, manufacturing
and other operations efficiently; (xvii) consumer acceptance of
NBTY's products; (xviii) the inability of NBTY to renew leases for
its retail locations; (xix) the inability of NBTY's retail stores
to attain or maintain profitability; (xx) the absence of clinical
trials for many of NBTY's products; (xxi) sales and earnings
volatility and/or trends for the Company and its market segments;
(xxii) the efficacy of NBTY's Internet and on-line sales and
marketing strategies; (xxiii) fluctuations in foreign currencies,
including the British pound, the Euro and the Canadian dollar;
(xxiv) import-export controls on sales to foreign countries; (xxv)
the inability of NBTY to secure favorable new sites for, and delays
in opening, new retail and manufacturing locations; (xxvi)
introduction of and compliance with new federal, state, local or
foreign legislation or regulation or adverse determinations by
regulators anywhere in the world (including the banning of
products) and more particularly Good Manufacturing Practices in the
United States, the Food Supplements Directive and Traditional
Herbal Medicinal Products Directive in Europe and Section 404
requirements of the Sarbanes-Oxley Act of 2002; (xxvii) the mix of
NBTY's products and the profit margins thereon; (xxviii) the
availability and pricing of raw materials; (xxix) risk factors
discussed in NBTY's filings with the U.S. Securities and Exchange
Commission; (xxx) adverse effects on NBTY as a result of increased
energy prices and potentially reduced traffic flow to NBTY's retail
locations; (xxxi) adverse tax determinations; (xxxii) the loss of a
significant customer of the Company; (xxxiii) potential investment
losses as a result of liquidity conditions; and (xxxiv) other
factors beyond the Company's control. Readers are cautioned not to
place undue reliance on forward-looking statements. NBTY cannot
guarantee future results, trends, events, levels of activity,
performance or achievements. NBTY does not undertake and
specifically declines any obligation to update, republish or revise
forward-looking statements to reflect events or circumstances after
the date hereof or to reflect the occurrences of unanticipated
events. Consequently, such forward-looking statements should be
regarded solely as NBTY's current plans, estimates and beliefs.
(TABLES FOLLOW) NBTY, INC. CONDENSED CONSOLIDATED STATEMENTS OF
INCOME (UNAUDITED) (In thousands, except per share amounts) Three
months ended June 30, 2009 2008 Net sales $ 651,707 $534,519 Costs
and expenses: Cost of sales 359,240 262,455 Advertising, promotion
and catalog 23,570 35,732 Selling, general and administrative
182,618 166,058 IT project termination costs 10,127 - 575,555
464,245 Income from operations 76,152 70,274 Other income
(expense): Interest (8,402) (3,721) Miscellaneous, net 3,396 2,417
(5,006) (1,304) Income before provision for income taxes 71,146
68,970 Provision for income taxes 25,229 23,444 Net income $ 45,917
$45,526 Net income per share: Basic $0.74 $0.74 Diluted $0.73 $0.72
Weighted average common shares outstanding: Basic 61,796 61,280
Diluted 63,264 62,830 NBTY, INC. CONDENSED CONSOLIDATED STATEMENTS
OF INCOME (UNAUDITED) (In thousands, except per share amounts) Nine
months ended June 30, 2009 2008 Net sales $1,907,813 $1,577,895
Costs and expenses: Cost of sales 1,091,386 764,069 Advertising,
promotion and catalog 87,889 108,908 Selling, general and
administrative 553,177 500,590 IT project termination costs 18,774
- 1,751,226 1,373,567 Income from operations 156,587 204,328 Other
income (expense): Interest (26,780) (11,239) Miscellaneous, net
(1,959) 11,089 (28,739) (150) Income before provision for income
taxes 127,848 204,178 Provision for income taxes 45,386 68,604 Net
income $ 82,462 $135,574 Net income per share: Basic $1.34 $2.11
Diluted $1.31 $2.06 Weighted average common shares outstanding:
Basic 61,665 64,105 Diluted 63,124 65,826 NET SALES (Unaudited)
THREE MONTHS ENDED JUNE 30, Percentage (In thousands) 2009 2008
Change Wholesale / US Nutrition $396,162 $283,645 40% North
American Retail 51,223 50,415 2% European Retail 151,293 145,670 4%
Direct Response / E-Commerce 53,029 54,789 -3% Total $651,707
$534,519 22% GROSS PROFIT PERCENTAGES (Unaudited) THREE MONTHS
ENDED JUNE 30, Increase 2009 2008 - Decrease Wholesale / US
Nutrition 33% 41% -8% North American Retail 67% 66% 1% European
Retail 61% 62% -1% Direct Response / E-Commerce 64% 58% 6% Total
45% 51% -6% NET SALES (Unaudited) NINE MONTHS ENDED JUNE 30,
Percentage (In thousands) 2009 2008 Change Wholesale / US Nutrition
$1,152,930 $801,943 44% North American Retail 151,577 158,501 -4%
European Retail 441,757 462,337 -4% Direct Response / E-Commerce
161,549 155,114 4% Total $1,907,813 $1,577,895 21% GROSS PROFIT
PERCENTAGES (Unaudited) NINE MONTHS ENDED JUNE 30, Increase 2009
2008 - Decrease Wholesale / US Nutrition 29% 42% -13% North
American Retail 67% 62% 5% European Retail 62% 62% 0% Direct
Response / E-Commerce 62% 59% 3% Total 43% 52% -9% ADJUSTED
EBITDA** Reconciliation of GAAP Measures to Non-GAAP Measures
(Unaudited) (In thousands) THREE MONTHS ENDED JUNE 30, 2009 Pretax
Depreciation Income and Non-cash Adjusted (Loss) amortization
Interest charges EBITDA** Wholesale / US Nutrition $61,905 $3,681
$- $24 $65,610 North American Retail (2,274) 758 - 5,560 4,044
European Retail 14,070 3,634 - 5,591 23,295 Direct Response /
E-Commerce 18,166 1,245 - 790 20,201 Segment Results 91,867 9,318 -
11,965 113,150 Corporate / Manufacturing (20,721) 7,486 8,402 832
(4,001) Total $71,146 $16,804 $8,402 $12,797 $109,149 THREE MONTHS
ENDED JUNE 30, 2008 Pretax Depreciation Income and Non-cash
Adjusted (Loss)* amortization Interest charges EBITDA** Wholesale /
US Nutrition $49,136 $2,587 $- $31 $51,754 North American Retail
1,873 750 - 18 2,641 European Retail 28,249 3,049 - 49 31,347
Direct Response / E-Commerce 6,044 1,248 - 23 7,315 Segment Results
85,302 7,634 - 121 93,057 Corporate / Manufacturing (16,332) 5,749
3,721 537 (6,325) Total $68,970 $13,383 $3,721 $658 $86,732 *
REFLECTS REVISED ALLOCATIONS OF CORPORATE/MANUFACTURING COSTS **
SINCE ADJUSTED EBITDA IS NOT A MEASURE OF PERFORMANCE CALCULATED IN
ACCORDANCE WITH U.S. GENERALLY ACCEPTED ACCOUNTING PRINCIPLES
("GAAP"), IT SHOULD NOT BE CONSIDERED IN ISOLATION OF, OR AS A
SUBSTITUTE FOR OR SUPERIOR TO, OTHER MEASURES OF FINANCIAL
PERFORMANCE PREPARED IN ACCORDANCE WITH GAAP, SUCH AS OPERATING
INCOME, NET INCOME AND CASH FLOWS FROM OPERATING ACTIVITIES. IN
ADDITION, THE COMPANY'S DEFINITION OF ADJUSTED EBITDA IS NOT
NECESSARILY COMPARABLE TO SIMILARLY TITLED MEASURES REPORTED BY
OTHER COMPANIES. ADJUSTED EBITDA** Reconciliation of GAAP Measures
to Non-GAAP Measures (Unaudited) (In thousands) NINE MONTHS ENDED
JUNE 30, 2009 Pretax Depreciation Income and Non-cash Adjusted
(Loss)* amortization Interest charges EBITDA** Wholesale / US
Nutrition $110,968 $10,991 $- $(3) $121,956 North American Retail
(4,160) 2,255 - 5,607 3,702 European Retail 60,559 10,598 - 5,681
76,838 Direct Response / E-Commerce 38,119 3,777 - 5,413 47,309
Segment Results 205,486 27,621 - 16,698 249,805 Corporate /
Manufacturing (77,638) 23,983 26,780 1,836 (25,039) Total $127,848
$51,604 $26,780 $18,534 $224,766 NINE MONTHS ENDED JUNE 30, 2008
Pretax Depreciation Income and Non-cash Adjusted (Loss)*
amortization Interest charges EBITDA** Wholesale / US Nutrition
$128,678 $7,858 $- $79 $136,615 North American Retail (1,733) 2,404
- 384 1,055 European Retail 97,582 9,081 - 90 106,753 Direct
Response / E-Commerce 25,699 3,988 - 43 29,730 Segment Results
250,226 23,331 - 596 274,153 Corporate / Manufacturing (46,048)
17,707 11,239 930 (16,172) Total $204,178 $41,038 $11,239 $1,526
$257,981 * REFLECTS REVISED ALLOCATIONS OF CORPORATE/MANUFACTURING
COSTS ** SINCE ADJUSTED EBITDA IS NOT A MEASURE OF PERFORMANCE
CALCULATED IN ACCORDANCE WITH U.S. GENERALLY ACCEPTED ACCOUNTING
PRINCIPLES ("GAAP"), IT SHOULD NOT BE CONSIDERED IN ISOLATION OF,
OR AS A SUBSTITUTE FOR OR SUPERIOR TO, OTHER MEASURES OF FINANCIAL
PERFORMANCE PREPARED IN ACCORDANCE WITH GAAP, SUCH AS OPERATING
INCOME, NET INCOME AND CASH FLOWS FROM OPERATING ACTIVITIES. IN
ADDITION, THE COMPANY'S DEFINITION OF ADJUSTED EBITDA IS NOT
NECESSARILY COMPARABLE TO SIMILARLY TITLED MEASURES REPORTED BY
OTHER COMPANIES. NBTY, Inc. Condensed Consolidated Balance Sheets
(Unaudited) (In thousands, except per share amounts) June 30,
September 30, 2009 2008 Current assets: Cash and cash equivalents
$69,817 $90,180 Accounts receivable, net 131,754 122,878
Inventories 634,613 585,239 Deferred income taxes 25,353 25,098
Other current assets 36,545 75,971 Total current assets 898,082
899,366 Property, plant and equipment, net 387,858 419,066 Goodwill
337,988 342,379 Intangible assets, net 216,726 230,424 Other assets
35,260 45,123 Total assets $1,875,914 $1,936,358 Current
liabilities: Current portion of long-term debt $31,635 $33,309
Accounts payable 106,999 120,620 Accrued expenses and other current
liabilities 145,732 172,035 Total current liabilities 284,366
325,964 Long-term debt, net of current portion 453,454 538,402
Deferred income taxes 38,737 49,139 Other liabilities 32,724 24,657
Total liabilities 809,281 938,162 Commitments and contingencies
Stockholders' equity: Common stock, $0.008 par; authorized 175,000
shares; issued and outstanding 61,872 and 61,599 shares at June 30,
2009 and September 30, 2008, respectively 495 493 Capital in excess
of par 144,493 140,990 Retained earnings 921,530 839,068
Accumulated other comprehensive income 115 17,645 Total
stockholders' equity 1,066,633 998,196 Total liabilities and
stockholders' equity $1,875,914 $1,936,358 NBTY, INC. CONDENSED
CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) (In thousands)
Nine Months ended June 30, 2009 2008 Cash flows from operating
activities: Net income $82,462 $135,574 Adjustments to reconcile
net income to cash provided by operating activities: Impairments
and disposals of assets 4,520 441 Depreciation and amortization
51,604 41,038 IT project termination costs 16,521 - Foreign
currency transaction loss (gain) 5,113 (1,594) Stock-based
compensation 2,013 1,176 Amortization of deferred charges 951 562
Allowance for doubtful accounts (366) (543) Inventory reserves
5,666 5,676 Deferred income taxes 888 1,372 Excess income tax
benefit from exercise of stock options (55) (4,984) Changes in
operating assets and liabilities, net of acquisitions: Accounts
receivable (11,129) (3,376) Inventories (63,228) (26,438) Other
assets 9,162 11,744 Accounts payable (7,061) 675 Accrued expenses
and other liabilities (8,915) 472 Net cash provided by operating
activities 88,146 161,795 Cash flows from investing activities:
Purchase of property, plant and equipment (38,584) (32,031)
Purchase of available-for-sale investments - (364,917) Proceeds
from sale of available-for-sale investments - 463,087 Cash paid for
acquisitions, net of cash acquired (264) (5,072) Acquisition
working capital escrow - (11,500) Escrow refund, net of purchase
price adjustments 14,460 - Net cash (used in) provided by investing
activities (24,388) 49,567 Cash flows from financing activities:
Principal payments under long-term debt agreements and capital
leases (25,176) (720) Proceeds from borrowings under the Revolving
Credit Facility 95,000 - Principal payments under the Revolving
Credit Facility (155,000) - Excess income tax benefit from exercise
of stock options 55 4,984 Proceeds from stock options exercised
1,437 3,852 Purchase of treasury stock (subsequently retired) -
(188,432) Net cash used in financing activities (83,684) (180,316)
Effect of exchange rate changes on cash and cash equivalents (437)
(1,972) Net (decrease) increase in cash and cash equivalents
(20,363) 29,074 Cash and cash equivalents at beginning of period
90,180 92,902 Cash and cash equivalents at end of period $69,817
$121,976 Contact: Harvey Kamil Carl Hymans NBTY, Inc. G.S. Schwartz
& Co. President and Chief Financial Officer 212-725-4500
631-200-2020 DATASOURCE: NBTY, Inc. CONTACT: Harvey Kamil, NBTY,
Inc., President and Chief Financial Officer, +1-631-200-2020; or
Carl Hymans, G.S. Schwartz & Co., +1-212-725-4500, Web Site:
http://www.nbty.com/
Copyright